Japan· JP-2655709N1100
ケトコナゾール
A ketoconazole product containing ケトコナゾール, registered in Japan by ＭＡＥ, on the national reimbursement list. The same ATC class is registered in 6 of our 19 countries.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
Where it is registered
Ketoconazole is registered in 6 of 19 countries.
Countries holding a registration under ATC H02CA03 (ketoconazole), each read from that country’s own register.
- This record: Japan, from MHLW / PMDA (Japan)
- 5 of them publish a price we can compare per daily dose
Ketoconazole · ATC H02CA03
6 / 19 countries
- Belgiumprice
- Czechiaprice
- Finlandprice
- Japan
- Norwayprice
- Polandprice
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- ケトコナゾール
- Manufacturer
- ＭＡＥ
- Country
- Japan (JP)
- ATC code
- H02CA03
- ATC class
- Ketoconazole
- Defined daily dose
- 0.6 g, O
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
818 interactions on record for ketoconazole.
Graded by severity as the source publishes them — 279 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Ketoconazole · interactions on record
818 records
- 279 severe
- 395 moderate
- 44 minor
- 100 info
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- NaloxegolA06AH03severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under H02CA03
Ketoconazole, as other registers publish it.
- NorwayKetoconazole EsteveEsteve Pharmaceuticals S.A
- FinlandKetoconazole EsteveEsteve Pharmaceuticals, S.A
- CzechiaKETOCONAZOLE ESTEVEEsteve Pharmaceuticals S.A., Barcelona
- BelgiumKetoconazole Esteve 200 mgEsteve Pharmaceuticals
- PolandKetoconazole HRAHRA Pharma Rare Diseases
- Japanケトコナゾール東光薬品工業
- Japanケトコナゾール帝國製薬
- Japanケトコナゾール日本ジェネリック
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/5320dad4-c2c9-4acb-a5c5-bc255481be91 GET /v1/drugs/5320dad4-c2c9-4acb-a5c5-bc255481be91?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "２％１ｇ",
"marks": "局",
"source": "mhlw",
"remarks": null,
"yj_code": "2655709N1100",
"category": "外用薬",
"price_yen": 12.5,
"generic_name": "ケトコナゾール",
"product_name_jp": null,
"therapeutic_class": "2655",
"transitional_expiry": null
}See everything about ketoconazole.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.